Kiniksa Pharmaceuticals International, Plc · NASDAQ:KNSA

Paolini John F. exercised options for 2,497 Kiniksa Pharmaceuticals International, Plc shares (Form 4)

Traded Apr 7, 2026 · Filed Apr 8, 2026

On Apr 7, 2026, Paolini John F. (CHIEF MEDICAL OFFICER) exercised options for 2,497 Kiniksa Pharmaceuticals International, Plc shares, leaving 65,623 shares. Filed Apr 8, 2026 (Form 4).

Options exercised
2,497 shares
Holding after
65,623 shares
Trading plan
No
Role
CHIEF MEDICAL OFFICER

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Apr 7, 2026Class A Ordinary ShareOption exercise2,49766,831Direct
Apr 7, 2026Class A Ordinary ShareShares withheld for tax1,208US$48.9465,623Direct

Source

View original at SEC

Related